Regulation of L-selectin expression by trauma-relevant cytokines

Pathology Research and Practice

Volumn 207, Issue 3, 2011, Pages 142-147

  Mommsen, P ^a   Barkhausen, T ^a   Hildebrand, F ^a   Zeckey, C ^a   Krettek, C ^a   van Griensven, M ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

Adhesion molecules; Cytokines; L selectin expression; Neutrophil extravasation; Regulation

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; L SELECTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; CELL STIMULATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MALE; POLYMORPHONUCLEAR CELL; POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; POSTOPERATIVE PERIOD; POSTTRAUMATIC COMPLICATION; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; SURGICAL INJURY;

ADULT; ANALYSIS OF VARIANCE; ANTERIOR CRUCIATE LIGAMENT; FEMALE; FLOW CYTOMETRY; GERMANY; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; L-SELECTIN; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; POSTERIOR CRUCIATE LIGAMENT; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79952440429     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.12.003     Document Type: Article

References (50)

1. Springer T.A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 1995, 57:827-872.
2. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2101.
3. Harlan J.M., Vedder N.B., Winn R.K., Rice C.L. Mechanisms and consequences of leukocyte-endothelial interaction. West. J. Med. 1991, 155:365-369.
4. Von Andrian U.H., Hansell P., Chambers J.D., Berger E.M., Torres Filho I., Butcher E.C., Arfors K.E. L-selectin function is required for beta 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am. J. Physiol. 1992, 263:H1034-1044.
5. Albelda S.M., Smith C.W., Ward P.A. Adhesion molecules and inflammatory injury. FASEB J. 1994, 8:504-512.
6. Bartunkova J., Maly P., Smetana K., Sediva A., Klubal R., Mayerova D., Sedlacek A., Splichalova V. Reduced phagocytic activity of polymorphonuclear leukocytes in alpha(1,3) fucosyltransferase VII-deficient mice. APMIS 2000, 108:409-416.
7. Smith C.W., Kishimoto T.K., Abbassi O., Hughes B., Rothlein R., McIntire L.V., Butcher E., Anderson D.C. Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J. Clin. Invest. 1991, 87:609-618.
8. Schlag G., Redl H.R., Till G.O., Davies J., Martin U., Dumont L. Anti-L-selectin antibody treatment of hemorrhagic-traumatic shock in baboons. Crit. Care Med. 1999, 27:1900-1907.
9. Seekamp A., van Griensven M., Dhondt E., Diefenbeck M., Demeyer I., Vundelinckx G., Haas N., Schaechinger U., Wolowicka L., Rammelt S., Stroobants J., Marzi I., Brambrink A.M., Dziurdzik P., Gasiorowski J., Redl H., Beckert M., Khan-Boluki J. The effect of anti-L-selectin (aselizumab) in multiple traumatized patients - results of a phase II clinical trial. Crit. Care Med. 2004, 32:2021-2028.
10. Hasslen S.R., Nelson R.D., Kishimoto T.K., Warren W.E., Ahrenholz D.H., Solem L.D. Down-regulation of homing receptors: a mechanism for impaired recruitment of human phagocytes in sepsis. J. Trauma 1991, 31:645-651. discussion 651-642.
11. Maekawa K., Futami S., Nishida M., Terada T., Inagawa H., Suzuki S., Ono K. Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J. Trauma 1998, 44:460-468.
12. Cocks R.A., Chan T.Y., Rainer T.H. Leukocyte L-selectin is up-regulated after mechanical trauma in adults. J. Trauma 1998, 45:1-6.
13. Muller J.C., Buhrer C., Kiening K.L., Kerner T., Gerlach H., Obladen M., Unterberg A.W., Lanksch W.R. Decreased soluble adhesion molecule L-selectin plasma concentrations after major trauma. J. Trauma 1998, 45:705-708.
14. van Griensven M., Barkhausen T., Hildebrand F., Grotz M., Mahlke L., Meier R., Seekamp A., Krettek C., Pape H.C. L-selectin shows time and gender dependency in association with MODS. Injury 2004, 35:1087-1095.
15. Thiel M., Zourelidis C., Chambers J.D., von Andrian U.H., Arfors K.E., Messmer K., Peter K. Expression of beta 2-integrins and L-selectin on polymorphonuclear leukocytes in septic patients. Eur. Surg. Res. 1997, 29:160-175.
16. McGill S.N., Ahmed N.A., Hu F., Michel R.P., Christou N.V. Shedding of L-selectin as a mechanism for reduced polymorphonuclear neutrophil exudation in patients with the systemic inflammatory response syndrome. Arch. Surg. 1996, 131:1141-1146. discussion 1147.
17. Seekamp A., van Griensven M., Hildebrandt F., Brauer N., Jochum M., Martin M. The effect of trauma on neutrophil L-selectin expression and sL-selectin serum levels. Shock 2001, 15:254-260.
18. Donnelly S.C., Haslett C., Dransfield I., Robertson C.E., Carter D.C., Ross J.A., Grant I.S., Tedder T.F. Role of selectins in development of adult respiratory distress syndrome. Lancet 1994, 344:215-219.
19. Rainer T.H., Lam N.Y., Chan T.Y., Cocks R.A. Early role of neutrophil L-selectin in posttraumatic acute lung injury. Crit. Care Med. 2000, 28:2766-2772.
20. Seidelin J.B., Nielsen O.H., Strom J. Soluble L-selectin levels predict survival in sepsis. Intensive Care Med. 2002, 28:1613-1618.
21. van Griensven M., Stalp M., Seekamp A. Ischemia-reperfusion directly increases pulmonary endothelial permeability in vitro. Shock 1999, 11:259-263.
22. Seekamp A., Regel G., Rother K., Jutila M. The effect of anti-L-selectin (EL-246) on remote lung injury after infrarenal ischemia/reperfusion. Shock 1997, 7:447-454.
23. Salas A., Sans M., Soriano A., Reverter J.C., Anderson D.C., Pique J.M., Panes J. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut 2000, 47:88-96.
24. Botha A.J., Moore F.A., Moore E.E., Sauaia A., Banerjee A., Peterson V.M. Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J. Trauma 1995, 39:411-417.
25. Ahmed N.A., Christou N.V. Decreased neutrophil L-selectin expression in patients with systemic inflammatory response syndrome. Clin. Invest. Med. 1996, 19:427-434.
26. Seekamp A., Jochum M., Ziegler M., van Griensven M., Martin M., Regel G. Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion. J. Trauma 1998, 44:874-882.
27. Hogevold H.E., Lyberg T., Kahler H., Reikeras O. Expression of beta-2-integrins and L-selectin by leukocytes and changes in acute-phase reactants in total hip replacement surgery. Eur. Surg. Res. 1996, 28:190-200.
28. Preece G., Murphy G., Ager A. Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J. Biol. Chem. 1996, 271:11634-11640.
29. Walcheck B., Alexander S.R., St Hill C.A., Matala E. ADAM-17-independent shedding of L-selectin. J. Leukoc. Biol. 2003, 74:389-394.
30. Schleiffenbaum B., Spertini O., Tedder T.F. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J. Cell Biol. 1992, 119:229-238.
31. Ferri L.E., Swartz D., Christou N.V. Soluble L-selectin at levels present in septic patients diminishes leukocyte-endothelial cell interactions in mice in vivo: a mechanism for decreased leukocyte delivery to remote sites in sepsis. Crit. Care Med. 2001, 29:117-122.
32. Tu L., Poe J.C., Kadono T., Venturi G.M., Bullard D.C., Tedder T.F., Steeber D.A. A functional role for circulating mouse L-selectin in regulating leukocyte/endothelial cell interactions in vivo. J. Immunol. 2002, 169:2034-2043.
33. Cipolle M.D., Pasquale M.D., Cerra F.B. Secondary organ dysfunction. From clinical perspectives to molecular mediators. Crit. Care Clin. 1993, 9:261-298.
34. Bown M.J., Horsburgh T., Nicholson M.L., Bell P.R., Sayers R.D. Cytokines, their genetic polymorphisms, and outcome after abdominal aortic aneurysm repair. Eur. J. Vasc. Endovasc. Surg. 2004, 28:274-280.
35. Pape H.C., van Griensven M., Rice J., Gansslen A., Hildebrand F., Zech S., Winny M., Lichtinghagen R., Krettek C. Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical markers. J. Trauma 2001, 50:989-1000.
36. Pinsky M.R., Vincent J.L., Deviere J., Alegre M., Kahn R.J., Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993, 103:565-575.
37. Riche F., Panis Y., Laisne M.J., Briard C., Cholley B., Bernard-Poenaru O., Graulet A.M., Gueris J., Valleur P. High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Surgery 1996, 120:801-807.
38. Pruitt J.H., Welborn M.B., Edwards P.D., Harward T.R., Seeger J.W., Martin T.D., Smith C., Kenney J.A., Wesdorp R.I., Meijer S., Cuesta M.A., Abouhanze A., Copeland E.M., Giri J., Sims J.E., Moldawer L.L., Oldenburg H.S. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 1996, 87:3282-3288.
39. Cruickshank A.M., Fraser W.D., Burns H.J., Van Damme J., Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin. Sci. (Lond.) 1990, 79:161-165.
40. Neidhardt R., Keel M., Steckholzer U., Safret A., Ungethuem U., Trentz O., Ertel W. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J. Trauma 1997, 42:863-870. discussion 870-861.
41. Smith R.M., Giannoudis P.V., Bellamy M.C., Perry S.L., Dickson R.A., Guillou P.J. Interleukin-10 release and monocyte human leukocyte antigen-DR expression during femoral nailing. Clin. Orthop. Relat. Res. 2000, 233-240.
42. Naldini A., Borrelli E., Carraro F., Giomarelli P., Toscano M. Interleukin 10 production in patients undergoing cardiopulmonary bypass: evidence of inhibition of Th-1-type responses. Cytokine 1999, 11:74-79.
43. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172.
44. Ferri L.E., Pascual J., Seely A.J., Chaudhury P., Christou N.V. Soluble L-selectin attenuates tumor necrosis factor-alpha-mediated leukocyte adherence and vascular permeability: a protective role for elevated soluble L-selectin in sepsis. Crit. Care Med. 2002, 30:1842-1847.
45. Ferri L.E., Chia S., Benay C., Giannias B., Christou N.V. L-selectin shedding in sepsis limits leukocyte mediated microvascular injury at remote sites. Surgery 2009, 145:384-391.
46. Grabovsky V., Dwir O., Alon R. Endothelial chemokines destabilize L-selectin-mediated lymphocyte rolling without inducing selectin shedding. J. Biol. Chem. 2002, 277:20640-20650.
47. Haribabu B., Steeber D.A., Ali H., Richardson R.M., Snyderman R., Tedder T.F. Chemoattractant receptor-induced phosphorylation of L-selectin. J. Biol. Chem. 1997, 272:13961-13965.
48. Pavalko F.M., Walker D.M., Graham L., Goheen M., Doerschuk C.M., Kansas G.S. The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins via alpha-actinin: receptor positioning in microvilli does not require interaction with alpha-actinin. J. Cell Biol. 1995, 129:1155-1164.
49. Evans S.S., Schleider D.M., Bowman L.A., Francis M.L., Kansas G.S., Black J.D. Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. J. Immunol. 1999, 162:3615-3624.
50. Ivetic A., Deka J., Ridley A., Ager A. The cytoplasmic tail of L-selectin interacts with members of the Ezrin-Radixin-Moesin (ERM) family of proteins: cell activation-dependent binding of Moesin but not Ezrin. J. Biol. Chem. 2002, 277:2321-2329.